Cargando…
Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review
Colorectal cancer (CRC) remains an incurable disease. There are no effective noninvasive techniques that have achieved colorectal cancer (CRC) diagnosis, prognosis, survival and recurrence in clinic. To investigate colorectal cancer metabolism, we perform an electronic literature search, from 1998 t...
Autores principales: | Zhang, Fan, Zhang, Yuanyuan, Zhao, Weiwei, Deng, Kui, Wang, Zhuozhong, Yang, Chunyan, Ma, Libing, Openkova, Margarita S., Hou, Yan, Li, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471069/ https://www.ncbi.nlm.nih.gov/pubmed/28389626 http://dx.doi.org/10.18632/oncotarget.16727 |
Ejemplares similares
-
Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer
por: Xie, Hongyu, et al.
Publicado: (2017) -
Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2020) -
Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
por: Wu, Xingyun, et al.
Publicado: (2023) -
Metabolomics for Biomarker Discovery: Moving to the Clinic
por: Zhang, Aihua, et al.
Publicado: (2015) -
Metabolomics and Biomarkers for Drug Discovery
por: Yeung, Pollen K.
Publicado: (2018)